Aktis Oncology
Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.
3
Funding Rounds
$331.0m
Money raised
Overview
Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Aktis Oncology has raised a total of $331m in funding over 3 rounds.
Key Insights:
- Aktis Oncology September 2024 Series B Funding Round: $175m
- Aktis Oncology Series A round (extension), August 26, 2022: $84m
- Aktis Oncology Series A round, March 2021: $72m
Aktis Oncology September 2024 Series B Funding Round
$175m
Aktis Oncology Series A round (extension), August 26, 2022
$84m
Aktis Oncology Series A round, March 2021
$72m
Industries
Aktis Oncology is active in the following industries: